All articlesPSSD Support

Do SSRI sexual side effects ever go away?

Some people recover and some do not. The EMA changed SSRI labels in 2019 because sexual side effects can carry on after the tablets stop.

By Morten SkovPublished

For some people, SSRI sexual side effects go away. For some people they do not. Nobody can tell you which you are, because nobody has counted. What is not in doubt is that it happens: the European Medicines Agency accepted in 2019 that sexual side effects can carry on after an SSRI is stopped.

What it covers

Post-SSRI Sexual Dysfunction (PSSD) is the name for effects that carry on after an SSRI or SNRI is stopped. SSRIs include sertraline (Zoloft), fluoxetine (Prozac), paroxetine (Paxil, Seroxat) and citalopram (Celexa). SNRIs include venlafaxine (Effexor) and duloxetine (Cymbalta). Symptoms can start on the tablets and stay, or appear only after stopping.

Sexual
Genital numbness, lost desire, erectile dysfunction, absent or muted orgasm, genital pain, reduced nipple sensitivity
Emotional
Emotional numbing, feeling detached from yourself, depression, suicidal thoughts
Senses
“Other sensory problems involving skin, smell, taste or vision”
Thinking
Cognitive impairment, the brain fog people describe

Those four groups come from the diagnostic criteria published by Healy and an international panel in 2022. The last two are the ones people get told are unrelated, or anxiety. They are in the criteria.

It is recognised

In 2019 the European Medicines Agency, which licenses medicines across the EU, told manufacturers to put persistent sexual dysfunction on SSRI and SNRI labels. Health Canada followed in 2021. Both are documented by Healy and Mangin, 2024.

The label is the leaflet inside the box. If you were told this always settles within a few weeks, that is not what the regulators concluded.

BBC Panorama broadcast The Antidepressant Story on 19 June 2023, with patients describing it. The episode is on BBC iPlayer, available in the UK only.

How common is it

Two published estimates, from the same 2024 review:

Lüning, 2019
52.6% of former antidepressant users reported sexual dysfunction that persisted
Ben-Sheetrit, 2023
0.46% risk of irreversible sexual dysfunction, which the authors call an underestimate
Agreed figure
None

One in two hundred, or one in two. Healy and Mangin give four reasons for the gap, and none of them is that the symptoms are hard to see.

  • The trial that would settle it would be unethical. You cannot give volunteers a drug expecting to cause this.
  • There is no validated way to measure it. No agreed questionnaire, so no two studies count the same thing.
  • People do not say. Some are embarrassed. Some say it once, are dismissed, and stop raising it.
  • It is not recorded searchably. Even when a doctor is told, nobody counting cases can find the note.

If a prescriber tells you the odds, ask what the figure is based on.

The genital numbness study

Pirani and colleagues surveyed 2,179 people with a history of psychiatric treatment, published online in 2024 and in print in Social Psychiatry and Psychiatric Epidemiology, 2025.

Past antidepressants
13.2% reported persistent genital numbness (93 of 707)
Other psychiatric drugs
0.9% (1 of 102)
Adjusted odds
14.2 times higher

One limit, and it matters: this was a subsample of UnACoRN, a survey of sexual and gender minority people aged 15 to 29 in the US and Canada. It is not a population rate. What it shows is the size of the difference between two groups answering one question.

Why nobody has counted

Regulators do not store your words. They store a MedDRA code. Coded to something general like “sexual dysfunction”, a report cannot be found again by anyone looking for this pattern.

A specific term exists: Post-SSRI sexual dysfunction, code 10086208. Healy and Mangin report it “does not appear to have been adopted by regulators”.

The dictionary has the word. The systems counting are not using it.

MedDRA code 10086208
English term: Post-SSRI sexual dysfunction

Use it if you took an SSRI or SNRI. Write that exact wording in the free-text box, then describe your symptoms in your own words. “PSSD” is the patient name and is not in the dictionary, so do not use it on its own. Our reporting guide covers the UK, the US and 63 other countries.

What you can do

  1. Report it. Our reporting guide walks through your country’s form. No doctor needs to agree with you, you need no proof, and you can report years after stopping.
  2. Join the registry. A side effect report captures one reaction once. The registry records a person over time, which is what research needs.
  3. Watch someone else describe it. Benjamin, in the film above, is fourteen years into this. That is not a forecast for you, but it does show that being told it settles shortly is not always true. There are more interviews here.

Nobody can promise you recovery and nobody can tell you it is permanent. Both happen. Anyone quoting you a percentage is going past what has been published.

What can change is the record. That range stays as wide as it is until reports exist under a term that can be counted.

If you are struggling with your mental health, the Samaritans are on 116 123, free, at any hour.

If you are in crisis: 116 123 Samaritans (UK) 988 Lifeline (US) Find a helpline